Characterizing Individuals Fulfilling Clinical Criteria for Limbic-Predominant Age-Related TDP-43 Encephalopathy in a Tertiary Memory Clinic

Read full text
Authors: Colin Groot, Ismael L. Calandri, Ilse Bader, Diana I. Bocancea, Hannah de Bruin, Maria Carrigan, Lyduine Eisa Collij, Flora Hillegonde Duits, Suzie Kamps, Lotte A. de Koning, Afina W. Lemstra, Sophie E Mastenbroek
+18 more Roos M. Rikken, Bas G.J. van Tol, Marie R. Vermeiren, Alex J. Wesseling, Ye Xia, Charlotte Elisabeth Teunissen, Elsmarieke van de Giessen, Frederik Barkhof, Laura E. Jonkman, Casper de Boer, Annemieke J.M. Rozemüller, Anna Elisabeth Leeuwis, Annelies E. van der Vlies, Betty M. Tijms, Wiesje M. van der Flier, Yolande A.L. Pijnenburg, Emma M. Coomans, Rik Ossenkoppele
Cited by: 1
References: 49

Abstract

BACKGROUND AND OBJECTIVES: Limbic-predominant age-related TDP-43 encephalopathy (LATE) is characterized by an amnestic- and limbic-predominant phenotype, which can mimic Alzheimer disease (AD). In a memory clinic cohort, we tested whether clinical criteria for LATE can detect a clinical profile of LATE that is distinct from AD. METHODS: In this retrospective examination of a longitudinal memory clinic cohort from the Alzheimer Center Amsterdam, we included individuals with mild cognitive impairment (MCI) and dementia (aged >50 years). We classified individuals based on baseline data on cognition, atrophy, amyloid-status, and tau-status into Probable- and Possible-LATE, co-occurring LATE and AD (LATE-AD), and AD (without LATE). Next, we compared these groups on demographics, clinical features, cognition, and atrophy. RESULTS: < 0.01). DISCUSSION: Using an operationalization of clinical criteria for LATE, 8.2% of participants with MCI or dementia from our tertiary memory clinic were classified as Possible-LATE, Probable-LATE, or LATE-AD. Probable-LATE was characterized by a milder disease course than AD, whereas LATE-AD was characterized by a more aggressive disease course. This underscores the value of the proposed clinical criteria in identifying individuals with suspected LATE, who have distinct clinical trajectories from AD. Our findings, therefore, support the use of these criteria to improve diagnostic and prognostic accuracy in the memory clinic.

Fields of Study & Subjects

Traumatic Brain Injury Research Epilepsy research and treatment Genetic Neurodegenerative Diseases

Publication details

Journal / source
Neurology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
106
Issue
9
Pages
e214810–e214810
Publication date
16 April 2026
Language
EN